Role of CoA and acetyl-CoA in regulating cardiac fatty acid and glucose oxidation

Biochemical Society Transactions

Volumn 42, Issue 4, 2014, Pages 1043-1051

  Alrob, Osama Abo ^a   Lopaschuk, Gary D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acetyl CoA; Carnitine acetyltransferase; Fatty acid oxidation; Lysine acetylation; Malonyl CoA; SIRT3

Indexed keywords

ACETYL COENZYME A; ACETYLCARNITINE; CARNITINE; CARNITINE ACETYLTRANSFERASE; COENZYME A; FATTY ACID; GLUCOSE; INSULIN; LACTIC ACID; LYSINE; MALONYL COENZYME A; PROTEIN KINASE B; SIRTUIN 3; SIRTUIN 4;

ACETYLATION; CELLULAR STRESS RESPONSE; CITRIC ACID CYCLE; CONFERENCE PAPER; CYTOPLASM; DIABETES MELLITUS; DISEASE ASSOCIATION; ENERGY METABOLISM; ENERGY YIELD; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME REGULATION; ESTERIFICATION; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GLUCOSE OXIDATION; HEART DISEASE; HEART MITOCHONDRION; HEART MUSCLE METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRACELLULAR TRANSPORT; LIPID METABOLISM; METABOLIC DISORDER; METABOLIC RATE; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; OXIDATION REDUCTION REACTION;

ACETYL COENZYME A; ANIMALS; CARNITINE O-ACETYLTRANSFERASE; COENZYME A; FATTY ACIDS; GLUCOSE; HUMANS; LYSINE; OXIDATION-REDUCTION; SIRTUIN 3;

EID: 84905816041     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20140094     Document Type: Conference Paper

References (99)

1. Lopaschuk, G.D., Ussher, J.R., Folmes, C.D., Jaswal, J.S. and Stanley, W.C. (2010) Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90, 207-258
2. Idell-Wenger, J.A., Grotyohann, L.W. and Neely, J.R. (1978) Coenzyme A and carnitine distribution in normal and ischemic hearts. J. Biol. Chem. 253, 4310-4318
3. Oram, J.F., Suzanne, B.L. and Neely, J.R. (1973) Regulation of fatty acid utilization in isolated perfused rat hearts. J. Biol. Chem. 248, 5299-5309
4. Neely, J.R. and Morgan, H.E. (1974) Relationship between carbohydrate metabolism and energy balance of heart muscle. Annu. Rev. Physiol. 36, 413-459
5. Garland, P.B. and Randle, P.J. (1964) Regulation of glucose uptake by muscles. 10. Effects of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy, and of fatty acids, ketone bodies and pyruvate, on the glycerol output and concentrations of free fatty acids, long-chain fatty acyl-coenzyme A, glycerol phosphate and citrate-cycle intermediates in rat heart and diaphragm muscles. Biochem. J. 93, 678-687
6. Randle, P.J., Garland, P.B., Hales, C.N. and Newsholme, E.A. (1963) The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 281, 785-789
7. McGarry, J.D., Takabayashi, Y. and Foster, D.W. (1978) The role of malonyl-CoA in the coordination of fatty acid synthesis and oxidation in isolated rat hepatocytes. J. Biol. Chem. 253, 8294-8300
8. McGarry, J.D. and Foster, D.W. (1980) Regulation of hepatic fatty acid oxidation and ketone body production. Annu. Rev. Biochem. 49, 395-420
9. Reszko, A.E., Kasumov, T., Comte, B., Pierce, B.A., David, F., Bederman, I.R., Deutsch, J., Des Rosiers, C. and Brunengraber, H. (2001) Assay of the concentration and 13C-isotopic enrichment of malonyl-coenzyme A by gas chromatography-mass spectrometry. Anal. Biochem. 298, 69-75
10. Kudo, N., Barr, A.J., Barr, R.L., Desai, S. and Lopaschuk, G.D. (1995) High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J. Biol. Chem. 270, 17513-17520
11. Alam, N. and Saggerson, E.D. (1998) Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle. Biochem. J. 334, 233-241
12. Abu-Elheiga, L., Matzuk, M.M., Abo-Hashema, K.A. and Wakil, S.J. (2001) Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291, 2613-2616
13. Saddik, M., Gamble, J., Witters, L.A. and Lopaschuk, G.D. (1993) Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J. Biol. Chem. 268, 25836-25845
14. Dyck, J.R., Barr, A.J., Barr, R.L., Kolattukudy, P.E. and Lopaschuk, G.D. (1998) Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation. Am. J. Physiol. 275, H2122-H2129
15. Awan, M.M. and Saggerson, E.D. (1993) Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem. J. 295, 61-66
16. Goodwin, G.W. and Taegtmeyer, H. (1999) Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation. Am. J. Physiol. 277, E772-E777
17. Lee, G.Y., Kim, N.H., Zhao, Z.S., Cha, B.S. and Kim, Y.S. (2004) Peroxisomal-proliferator-activated receptor activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level. Biochem. J. 378, 983-990
18. Cuthbert, K.D. and Dyck, J.R. (2005) Malonyl-CoA decarboxylase is a major regulator of myocardial fatty acid oxidation. Curr. Hypertens. Rep. 7, 407-411
19. Kudo, N.B., Barr, R. and Lopaschuk, G.D. (1995) 5 AMP-activated protein kinase inhibition of acetyl CoA carboxylase can explain the high rates of fatty acid oxidation in reperfused ischemic hearts. J. Biol. Chem. 270, 17511-17520
20. Campbell, F.M., Kozak, R., Wagner, A., Altarejos, J.Y., Dyck, J.R., Belke, D.D., Severson, D.L., Kelly, D.P. and Lopaschuk, G.D. (2002) A role for peroxisome proliferator-activated receptor (PPAR) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPAR are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase. J. Biol. Chem. 277, 4098-4103
21. Young, M.E., Goodwin, G.W., Ying, J., Guthrie, P., Wilson, C.R., Laws, F.A. and Taegtmeyer, H. (2001) Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids. Am. J. Physiol. Endocrinol. Metab. 280, E471-E479
22. Dyck, J.R., Hopkins, T.A., Bonnet, S., Michelakis, E.D., Young, M.E., Watanabe, M., Kawase, Y., Jishage, K. and Lopaschuk, G.D. (2006) Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury. Circulation 114, 1721-1728
23. Dyck, J.R., Cheng, J.F., Stanley, W.C., Barr, R., Chandler, M.P., Brown, S., Wallace, D., Arrhenius, T., Harmon, C., Yang, G. et al. (2004) Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Circ. Res. 94, e78-e84
24. Marquis, N.R. and Fritz, I.B. (1965) The distribution of carnitine, acetylcarnitine, and carnitine acetyltransferase in rat tissues. J. Biol. Chem. 240, 2193-2196
25. Roskoski, Jr, R., Schmid, P.G., Mayer, H.E. and Abboud, F.M. (1975) In vitro acetylcholine biosynthesis in normal and failing guinea pig hearts. Circ. Res. 36, 547-552
26. Schonekess, B.O., Allard, M.F. and Lopaschuk, G.D. (1995) PropionylL-carnitine improvement of hypertrophied rat heart function is associated with an increase in cardiac efficiency. Eur. J. Pharmacol. 286, 155-166
27. Broderick, T.L., Quinney, H.A. and Lopaschuk, G.D. (1992) Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J. Biol. Chem. 267, 3758-3763
28. Schonekess, B.O., Allard, M.F. and Lopaschuk, G.D. (1995) Propionyl l-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ. Res. 77, 726-734
29. Lopaschuk, G.D., Belke, D.D., Gamble, J., Itoi, T. and Schonekess, B.O. (1994) Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim. Biophys. Acta 1213, 263-276
30. Abbas, A.S., Wu, G. and Schulz, H. (1998) Carnitine acetyltransferase is not a cytosolic enzyme in rat heart and therefore cannot function in the energy-linked regulation of cardiac fatty acid oxidation. J. Mol. Cell. Cardiol. 30, 1305-1309
31. Xiong, Y. and Guan, K.L. (2012) Mechanistic insights into the regulation of metabolic enzymes by acetylation. J. Cell Biol. 198, 155-164
32. Sack, M.N. and Finkel, T. (2012) Mitochondrial metabolism, sirtuins, and aging. Cold Spring Harb. Perspect. Biol. 10, 1101-13102
33. Pillai, V.B., Sundaresan, N.R. and Gupta, M.P. (2014) Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging. Circ. Res. 114, 368-378
34. Newman, J.C., He, W. and Verdin, E. (2012) Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease. J. Biol. Chem. 287, 42436-42443
35. Anderson, K.A. and Hirschey, M.D. (2012) Mitochondrial protein acetylation regulates metabolism. Essays Biochem. 52, 23-35
36. Shaw, B.F., Schneider, G.F., Bilgicer, B., Kaufman, G.K., Neveu, J.M., Lane, W.S., Whitelegge, J.P. and Whitesides, G.M. (2008) Lysine acetylation can generate highly charged enzymes with increased resistance toward irreversible inactivation. Protein Sci. 17, 1446-1455
37. Tong, L. and Denu, J.M. (2010) Function and metabolism of sirtuin metabolite O-acetyl-ADP-ribose. Biochim. Biophys. Acta 1804, 1617-1625
38. Zhao, K., Harshaw, R., Chai, X. and Marmorstein, R. (2004) Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD+ -dependent Sir2 histone/protein deacetylases. Proc. Natl. Acad. Sci. U. S.A. 101, 8563-8568
39. Verdin, E. (2014) The many faces of sirtuins: coupling of NAD metabolism, sirtuins and lifespan. Nat. Med. 20, 25-27
40. Fiorino, E., Giudici, M., Ferrari, A., Mitro, N., Caruso, D., De Fabiani, E. and Crestani, M. (2014) The sirtuin class of histone deacetylases: regulation and roles in lipid metabolism. IUBMB Life 66, 89-99
41. Chang, H.C. and Guarente, L. (2013) SIRT1 and other sirtuins in metabolism. Trends Endocrinol. Metab. 25, 138-145
42. Frye, R.A. (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273, 793-798
43. Michishita, E., Park, J.Y., Burneskis, J.M., Barrett, J.C. and Horikawa, I. (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 16, 4623-4635
44. Li, X. and Kazgan, N. (2011) Mammalian sirtuins and energy metabolism. Int. J. Biol. Sci. 7, 575-587
45. Chalkiadaki, A. and Guarente, L. (2012) Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat. Rev. Endocrinol. 8, 287-296
46. Cen, Y., Youn, D.Y. and Sauve, A.A. (2011) Advances in characterization of human sirtuin isoforms: chemistries, targets and therapeutic applications. Curr. Med. Chem. 18, 1919-1935
47. Ramakrishnan, G., Davaakhuu, G., Kaplun, L., Chung, W.C., Rana, A., Atfi, A., Miele, L. and Tzivion, G. (2014) Sirt2 deacetylase is a novel Akt binding partner critical for Akt activation by insulin. J. Biol. Chem. 289, 6054-6066
48. Wu, G., Song, C., Lu, H., Jia, L., Yang, G., Shi, X. and Sun, S. (2014) Sirt2 induces C2C12 myoblasts proliferation by activation of the ERK1/2 pathway. Acta Biochim. Biophys. Sin. 46, 342-345
49. Rodgers, J.T., Lerin, C., Haas, W., Gygi, S.P., Spiegelman, B.M. and Puigserver, P. (2005) Nutrient control of glucose homeostasis through a complex of PGC-1 and SIRT1. Nature 434, 113-118
50. Gerhart-Hines, Z., Rodgers, J.T., Bare, O., Lerin, C., Kim, S.H., Mostoslavsky, R., Alt, F.W., Wu, Z. and Puigserver, P. (2007) Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1. EMBO J. 26, 1913-1923
51. Lim, J.H., Gerhart-Hines, Z., Dominy, J.E., Lee, Y., Kim, S., Tabata, M., Xiang, Y.K. and Puigserver, P. (2013) Oleic acid stimulates complete oxidation of fatty acids through protein kinase A-dependent activation of SIRT1-PGC1 complex. J. Biol. Chem. 288, 7117-7126
52. Nemoto, S., Fergusson, M.M. and Finkel, T. (2005) SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1. J. Biol. Chem. 280, 16456-16460
53. Canto, C. and Auwerx, J. (2009) PGC-1, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 20, 98-105
54. Price, N.L., Gomes, A.P., Ling, A.J., Duarte, F.V., Martin-Montalvo, A., North, B.J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J.S. et al. (2012) SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 15, 675-690
55. Jaswal, J.S., Keung, W., Wang, W., Ussher, J.R. and Lopaschuk, G.D. (2011) Targeting fatty acid and carbohydrate oxidation: a novel therapeutic intervention in the ischemic and failing heart. Biochim. Biophys. Acta 1813, 1333-1350
56. Han, L., Zhou, R., Niu, J., McNutt, M.A., Wang, P. and Tong, T. (2010) SIRT1 is regulated by a PPAR -SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res. 38, 7458-7471
57. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado De Oliveira, R., Leid, M., Mcburney, M.W. and Guarente, L. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR. Nature 429, 771-776
58. Purushotham, A., Schug, T.T., Xu, Q., Surapureddi, S., Guo, X. and Li, X. (2009) Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 9, 327-338
59. Rardin, M.J., Newman, J.C., Held, J.M., Cusack, M.P., Sorensen, D.J., Li, B., Schilling, B., Mooney, S.D., Kahn, C.R., Verdin, E. et al. (2013) Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways. Proc. Natl. Acad. Sci. U.S.A. 110, 6601-6606
60. Banks, A.S., Kon, N., Knight, C., Matsumoto, M., Gutierrez-Juarez, R., Rossetti, L., Gu, W. and Accili, D. (2008) SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 8, 333-341
61. Sundaresan, N.R., Pillai, V.B., Wolfgeher, D., Samant, S., Vasudevan, P., Parekh, V., Raghuraman, H., Cunningham, J.M., Gupta, M. and Gupta, M.P. (2011) The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci. Signal. 182, ra46
62. Milne, J.C., Lambert, P.D., Schenk, S., Carney, D.P., Smith, J.J., Gagne, D.J., Jin, L., Boss, O., Perni, R.B., Vu, C.B. et al. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716
63. Sol, E.M., Wagner, S.A., Weinert, B.T., Kumar, A., Kim, H.S., Deng, C.X. and Choudhary, C. (2012) Proteomic investigations of lysine acetylation identify diverse substrates of mitochondrial deacetylase sirt3. PLoS ONE 7, e50545
64. Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H. et al. (2010) Regulation of cellular metabolism by protein lysine acetylation. Science 327, 1000-1004
65. Hirschey, M.D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D.B., Grueter, C.A., Harris, C., Biddinger, S., Ilkayeva, O.R. et al. (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121-125
66. Hirschey, M.D., Shimazu, T., Jing, E., Grueter, C.A., Collins, A.M., Aouizerat, B., Stancáková, A., Goetzman, E., Lam, M.M., Schwer, B. et al. (2011) SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 44, 177-190
67. Hebert, A.S., Dittenhafer-Reed, K.E., Yu, W., Bailey, D.J., Selen, E.S., Boersma, M.D., Carson, J.J., Tonelli, M., Balloon, A.J., Higbee, A.J. et al. (2013) Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell 49, 186-199
68. Fan, J., Shan, C., Kang, H.B., Elf, S., Xie, J., Tucker, M., Gu, T.L., Aguiar, M., Lonning, S., Chen, H. et al. (2014) Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex. Mol. Cell 53, 534-548
69. Jing, E., O'Neill, B.T., Rardin, M.J., Kleinridders, A., Ilkeyeva, O.R., Ussar, S., Bain, J.R., Lee, K.Y., Verdin, E.M., Newgard, C.B. et al. (2013) Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 62, 3404-3417
70. Lombard, D.B., Alt, F.W., Cheng, H.L., Bunkenborg, J., Streeper, R.S., Mostoslavsky, R., Kim, J., Yancopoulos, G., Valenzuela, D., Murphy, A. et al. (2007) Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 27, 8807-8814
71. Schlicker, C., Gertz, M., Papatheodorou, P., Kachholz, B., Becker, C.F. and Steegborn, C. (2008) Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J. Mol. Biol. 382, 790-801
72. Cimen, H., Han, M.J., Yang, Y., Tong, Q., Koc, H. and Koc, E.C. (2010) Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 49, 304-311
73. Finley, L.W., Haas, W., Desquiret-Dumas, V., Wallace, D.C., Procaccio, V., Gygi, S.P. and Haigis, M.C. (2011) Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS ONE 6, e23295
74. Bharathi, S.S., Zhang, Y., Mohsen, A.W., Uppala, R., Balasubramani, M., Schreiber, E., Uechi, G., Beck, M.E., Rardin, M.J., Vockley, J. et al. (2013) Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site. J. Biol. Chem. 288, 33837-33847
75. Zhang, L., Ussher, J.R., Oka, T., Cadete, V.J., Wagg, C. and Lopaschuk, G.D. (2011) Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation. Cardiovasc. Res. 89, 148-156
76. Zhang, L., Mori, J., Wagg, C. and Lopaschuk, G.D. (2012) Activating cardiac E2F1 induces up-regulation of pyruvate dehydrogenase kinase 4 in mice on a short term of high fat feeding. FEBS Lett. 586, 996-1003
77. Ussher, J.R., Koves, T.R., Jaswal, J.S., Zhang, L., Ilkayeva, O., Dyck, J.R., Muoio, D.M. and Lopaschuk, G.D. (2009) Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase. Diabetes 58, 1766-1775
78. Keung, W., Ussher, J.R., Jaswal, J.S., Raubenheimer, M., Lam, V.H., Wagg, C.S. and Lopaschuk, G.D. (2013) Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice. Diabetes 62, 711-720
79. Jing, E., Emanuelli, B., Hirschey, M.D., Boucher, J., Lee, K.Y., Lombard, D., Verdin, E.M. and Kahn, C.R. (2011) Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc. Natl. Acad. Sci. U.S.A. 108, 14608-14613
80. Palacios, O.M., Carmona, J.J., Michan, S., Chen, K.Y., Manabe, Y., Ward, J.L., Goodyear, L.J. and Tong, Q. (2009) Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1 in skeletal muscle. Aging 1, 771-783
81. Pougovkina, O., Te Brinke, H., Ofman, R., van Cruchten, A.G., Kulik, W., Wanders, R.J., Houten, S.M. and de Boer, V.C. (2014) Mitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation. Hum. Mol. Genet. 23, 3513-3522
82. Nasrin, N., Wu, X., Fortier, E., Feng, Y., Bare, O.C., Chen, S., Ren, X., Wu, Z., Streeper, R.S. and Bordone, L. (2010) SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J. Biol. Chem. 285, 31995-32002
83. Haigis, M.C., Mostoslavsky, R., Haigis, K.M., Fahie, K., Christodoulou, D.C., Murphy, A.J., Valenzuela, D.M., Yancopoulos, G.D., Karow, M., Blander, G. et al. (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic β cells. Cell 126, 941-954
84. Laurent, G., German, N.J., Saha, A.K., de Boer, V.C., Davies, M., Koves, T.R., Dephoure, N., Fischer, F., Boanca, G., Vaitheesvaran, B. et al. (2013) SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Mol. Cell 50, 686-698
85. Laurent, G., de Boer, V.C., Finley, L.W., Sweeney, M., Lu, H., Schug, T.T., Cen, Y., Jeong, S.M., Li, X., Sauve, A.A. et al. (2013) SIRT4 represses peroxisome proliferator-activated receptor activity to suppress hepatic fat oxidation. Mol. Cell. Biol. 33, 4552-4561
86. Mori, J., Alrob, O.A., Wagg, C.S., Harris, R.A., Lopaschuk, G.D. and Oudit, G.Y. (2013) ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4. Am. J. Physiol. Heart Circ. Physiol. 304, H1103-H1113
87. Haberland, M., Montgomery, R.L. and Olson, E.N. (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32-42
88. Gray, S.G. and De Meyts, P. (2005) Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes Metab. Res. Rev. 21, 416-433
89. de Kreutzenberg, S.V., Ceolotto, G., Papparella, I., Bortoluzzi, A., Semplicini, A., Dalla Man, C., Cobelli, C., Fadini, G.P. and Avogaro, A. (2010) Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 59, 1006-1015
90. Deng, X.Q., Chen, L.L. and Li, N.X. (2007) The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats. Liver Int. 27, 708-715
91. Kaiser, C. and James, S.R. (2004) Acetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylation. BMC Biol. 2, 23
92. Zhang, J. (2007) The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation. J. Biol. Chem. 282, 34356-34364
93. Kendrick, A.A., Choudhury, M., Rahman, S.M., McCurdy, C.E., Friederich, M., Van Hove, J.L., Watson, P.A., Birdsey, N., Bao, J., Gius, D. et al. (2011) Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem. J. 433, 505-514
94. Grillon, J.M., Johnson, K.R., Kotlo, K. and Danziger, R.S. (2012) Non-histone lysine acetylated proteins in heart failure. Biochim. Biophys. Acta 822, 607-614
95. Sundaresan, N.R., Gupta, M., Kim, G., Rajamohan, S.B., Isbatan, A. and Gupta, M.P. (2009) Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 119, 2758-2771
96. Pillai, V.B., Sundaresan, N.R., Kim, G., Gupta, M., Rajamohan, S.B., Pillai, J.B., Samant, S., Ravindra, P.V., Isbatan, A. and Gupta, M.P. (2010) Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J. Biol. Chem. 285, 3133-3144
97. Karamanlidis, G., Lee, C.F., Garcia-Menendez, L., Kolwicz, S.C., Suthammarak, W., Gong, G., Sedensky, M.M., Morgan, P.G., Wang, W. and Tian, R. (2013) Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure. Cell Metab. 18, 239-250
98. Alcendor, R.R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S.F. and Sadoshima, J. (2007) Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100, 1512-1521
99. Oka, S., Alcendor, R., Zhai, P., Park, J.Y., Shao, D., Cho, J., Yamamoto, T., Tian, B. and Sadoshima, J. (2011) PPAR-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway. Cell Metab. 14, 598-611